Conjunctival edema, unspecified eye
ICD-10 H11.429 is a billable code used to indicate a diagnosis of conjunctival edema, unspecified eye.
Conjunctival edema, unspecified eye, refers to the swelling of the conjunctiva, the thin membrane that covers the white part of the eyeball and the inner surface of the eyelids. This condition can manifest as redness, irritation, and a sensation of fullness or pressure in the affected eye. The conjunctiva plays a crucial role in protecting the eye and maintaining moisture. Edema can result from various underlying causes, including allergic reactions, infections, or systemic conditions such as hypertension. The disease progression may vary; acute cases may resolve quickly with appropriate treatment, while chronic edema may indicate ongoing inflammation or other serious conditions. Diagnostic considerations include a thorough patient history, physical examination, and possibly additional tests such as conjunctival scraping or allergy testing to determine the underlying cause. It is essential to differentiate conjunctival edema from other ocular disorders, such as scleral or corneal edema, which may require different management strategies.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
H11.429 encompasses conjunctival edema due to various causes, including allergic conjunctivitis, viral or bacterial infections, and irritants. It does not specify the underlying etiology, making it a catch-all for unspecified conjunctival swelling.
H11.429 should be used when the specific eye affected is not documented, or when the cause of the conjunctival edema is unknown. If the condition is localized to one eye or has a known etiology, more specific codes should be utilized.
Documentation should include a detailed patient history, clinical findings, and any diagnostic tests performed. Notes should clearly indicate the symptoms, duration, and any treatments attempted to support the use of H11.429.
